CAITLIN WILLIAMS: Open Payments
NPI 1437622909 · THAXTON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,081 in 107 payments from 11 companies in 2025. Trend: 2023 $1,597 · 2024 $2,105 · 2025 $2,081
Food & beverage: $2,063Education: $17
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 23 | $405 |
| ABBVIE INC. | 19 | $352 |
| Paratek Pharmaceuticals, Inc. | 16 | $339 |
| Gilead Sciences, Inc. | 19 | $310 |
| Merck Sharp & Dohme LLC | 10 | $233 |
| Theratechnologies Inc. | 6 | $142 |
| La Jolla Pharmaceutical Company | 5 | $103 |
| Insmed, Inc. | 5 | $94 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
| Teleflex LLC | 1 | $38 |
Products named: NUZYRA, DOVATO, PIFELTRO, AVYCAZ, EGRIFTA, CABENUVA, Arikayce, DALVANCE.
Industry payments across MS — which companies pay providers there.
